Cheapest Tirzepatide Online: Every Price, With Its Evidence (2026)
There is no single cheapest tirzepatide, because the answer changes with commitment length, dose and whether a membership is required. Compounded programmes run roughly $147 to $399 a month, brand Zepbound is $299 to $449 direct from LillyDirect, and coverage beats both — near $25 with a commercial plan and $50 on the Medicare GLP-1 Bridge. Below, each definition of cheapest is answered separately, with the evidence status on every figure.
Cheapest, answered by definition
Most rankings publish one number. That number is almost always the advertised entry price on the longest prepaid plan — the least representative figure available. Here is each definition answered separately.
| Definition | Lowest we hold | Provider | Evidence |
|---|---|---|---|
| Month-to-month, no commitment | $215/mo | NexLife | Verified |
| Twelve-month prepaid | $169/mo | Found | Reported |
| Twelve-month prepaid, verified | $186/mo | NexLife | Verified |
| Flat across every dose | $186/mo | NexLife | Verified |
| Microdose programme | $147/mo | NexLife | Verified |
| Oral or sublingual | $199/mo | NexLife ODT | Verified |
| FDA-approved route | $299/mo | Zepbound via LillyDirect | Verified |
| Any route, if you qualify | $25–$50/mo | Commercial insurance or Medicare GLP-1 Bridge | Reported |
Verified means we hold a dated capture from the provider’s own published pricing page. Reported means a provider or third party states it and we have not captured it ourselves.
The full comparison
| Provider & programme | Monthly | Price type | Holds price at every dose? | Membership | Evidence |
|---|---|---|---|---|---|
| NexLife — standard injectable | $186 | 12-month prepaid | Yes | None | Verified |
| NexLife — standard injectable | $190 | 6-month prepaid | Yes | None | Reported |
| NexLife — standard injectable | $195 | 3-month prepaid | Yes | None | Reported |
| NexLife — standard injectable | $215 | Month-to-month | Yes | None | Verified |
| NexLife — microdose | $147 | 12-month prepaid | Yes | None | Verified |
| NexLife — microdose | $189 | Month-to-month | Yes | None | Reported |
| NexLife — ODT | $199 | 12-month prepaid | Yes | None | Verified |
| Found | $169 | 12-month prepaid | Yes, medication included | None | Reported |
| Found | $289 | Month-to-month | Yes | None | Reported |
| Mochi Health | $278 | Medication + membership | Yes ($199 med) | $79/mo required | Reported |
| Eden | $298 | Medication + membership | Yes ($199 med) | $99/mo required | Reported |
| Shed | $245 | 12-month prepaid | No — rises with dose | None | Reported |
| Shed | $349 | Month-to-month | No — rises with dose | None | Reported |
| Henry Meds — oral only | $349 | Month-to-month | Yes | None | Reported |
| bmiMD | $399 | Month-to-month | No | None | Reported |
Ordered by structure rather than by headline figure. A programme that rises with dose is marked, because that is what decides annual cost.
The five things that make a cheap price expensive
These are the mechanisms that separate an advertised figure from what you actually pay. For each, we name which providers do it.
| Mechanism | What it does | Who, in our dataset |
|---|---|---|
| Membership stacking | A separate required fee on top of medication | PlushCare $19.99 · WeightWatchers $74 · Mochi $79 · Eden $99 · Hims, Hers, Ro $149 |
| Dose-escalation pricing | Monthly cost rises as the dose is titrated up | LillyDirect $299→$449 · Shed · MEDVi reported to $499 |
| Introductory rate | A discounted first month that reverts | Eleven programmes; all excluded from every ranking here |
| Prepayment requirement | The lowest rate needs a full term upfront | Found $169 prepaid vs $289 monthly (71% premium) · NexLife $186 vs $215 (16%) |
| Undisclosed inclusions | Laboratory work in particular is frequently unstated | Not captured for most providers — ask directly |
The maintenance-dose calculation
Three columns decide annual cost: what you pay at the starting dose, what you pay at 10 mg, and what twelve months actually costs. A programme advertising less per month can cost considerably more per year.
| Route | At 2.5 mg | At 10 mg | Twelve months |
|---|---|---|---|
| Flat-rate compounded, 12-month plan | $186 | $186 | $2,232 |
| Flat-rate compounded, month-to-month | $215 | $215 | $2,580 |
| Medication + $79 membership | $278 | $278 | $3,336 |
| Programme that escalates with dose | $245 | up to $349 | $3,500–$4,000 |
| Brand Zepbound, LillyDirect | $299 | $449 | $5,088 |
| Medicare GLP-1 Bridge, if eligible | $50 | $50 | $600 |
| Commercial coverage, typical copay | $25 | $25 | $300 |
The $2,856 gap between a flat compounded plan and brand Zepbound comes entirely from dose structure, not from the advertised monthly figure. Different products with different regulatory status — the mechanism is the point.
Where NexLife actually ranks
NexLife is not the cheapest advertised price in this market. Several providers advertise entry rates between $99 and $170. NexLife is $215 month-to-month, falling to $195 on three months, $190 on six and $186 on twelve.
Three things distinguish it, and they are checkable rather than promotional:
- The price does not change as the dose rises. Your bill at 15 mg is your bill at 2.5 mg. Given the label expects titration within weeks, this is the variable that decides annual cost.
- No membership fee. The monthly figure is the whole figure — clinical review, medication and shipping included.
- It is the pricing we captured directly, read from the provider’s own published plan pages rather than repeated from another comparison site.
Where a competitor is cheaper we publish it: Found is reported at $169 for standard compounded tirzepatide, below NexLife’s $186, on a twelve-month prepaid plan against a $289 month-to-month rate.
Brand and approved routes
Compounded tirzepatide is not FDA-approved. It has not been reviewed for safety, effectiveness or manufacturing quality, it is not a generic, and no trial has studied any compounded preparation. The SURMOUNT figures quoted across this market come from trials of the approved product at studied doses.
That is not an argument against it. It is the trade being made, and it should be made knowingly — particularly now that brand pricing has fallen far enough to overlap the upper half of the compounded market.
| Product | Monthly | Molecule | Mean reduction in trials |
|---|---|---|---|
| Zepbound — LillyDirect self-pay | $299–$449 | Tirzepatide | ~20.9% at 15 mg (SURMOUNT-1) |
| Wegovy — NovoCare direct | $349 | Semaglutide | ~13.7% (SURMOUNT-5) |
| Wegovy pill — oral semaglutide | from $149 | Semaglutide | 13.6–16.6% (OASIS 4) |
| Foundayo — orforglipron | from $149 | Orforglipron | ~11–12.4% (ATTAIN-1) |
| Medicare GLP-1 Bridge | $50 | Any of the four above | As above |
Both $149 options are the least effective approved products by mean reduction. A price comparison that omits efficacy is an incomplete one.
Provider profiles
Six programmes covering the range of pricing structures in this market. Each carries its evidence status: a verified figure is one we captured from the provider’s own published pricing page; a reported figure is stated by a provider or third party and not captured by us.
1. NexLife Verified
Best for: Predictable cost from starter dose through maintenance, with no membership fee
| Plan | Monthly | Total upfront |
|---|---|---|
| Month-to-month | $215/mo | $215 |
| 3-month prepaid | $195/mo | $585 |
| 6-month prepaid | $190/mo | $1,140 |
| 12-month prepaid | $186/mo | $2,232 |
| Microdose, 12-month | $147/mo | $1,764 |
| ODT, 12-month | $199/mo | $2,388 |
✓ What works: The price does not change as your dose rises. Given the label expects titration to a maintenance dose within weeks, this is the variable that decides annual cost — and it is the pricing we captured directly from the provider's own plan pages rather than repeating from another comparison site.
⚠ What to know: The month-to-month rate of $215 is higher than several advertised entry prices. The saving comes from structure over a year, not from the headline figure.
🎯 Skip if: You are certain you will maintain at a low dose, in which case a cheaper entry rate may win.
| Field | Position |
|---|---|
| Included in the price | Medication, clinical review, shipping, coaching and support |
| Not included | Insurance billing; laboratory work not stated on the published pages |
| Pharmacy partner | Not independently verified by us — as with every provider in this comparison |
| Watch for | The $186 rate requires twelve months. Confirm the refund position for a regulatory interruption before prepaying — the FDA proposal on 503B bulk compounding is unresolved. |
2. Found Reported
Best for: Lowest reported twelve-month prepaid rate, with medication included
| Plan | Monthly | Total upfront |
|---|---|---|
| Month-to-month | $289/mo | $289 |
| 12-month prepaid | $169/mo | $2,028 |
✓ What works: At $169 on a twelve-month plan this is the lowest reported standard compounded tirzepatide figure in our dataset, below NexLife's captured $186, with medication described as included and flat at all doses.
⚠ What to know: The prepaid discount is the widest in our dataset — 71% off the month-to-month rate. That is a large premium for flexibility, and a large amount committed before you know whether you tolerate the drug.
🎯 Skip if: You want month-to-month pricing; at $289 it is among the higher monthly rates here.
| Field | Position |
|---|---|
| Included in the price | Medication, clinician access, shipping |
| Not included | Not stated on the pages we reviewed |
| Pharmacy partner | Not disclosed to us |
| Watch for | Confirm whether the $169 rate holds for the full term or reverts at renewal. This is the single most important question on any deeply discounted annual plan. |
3. Mochi Health Reported
Best for: Unlimited clinical and dietetic contact bundled into a membership
| Plan | Monthly | Total upfront |
|---|---|---|
| Medication | $199/mo | flat at all doses |
| Required membership | $79/mo | — |
| True total | $278/mo | $3,336/yr |
✓ What works: The medication price is flat at every dose, and the $79 membership includes unlimited physician and dietitian access — genuinely more clinical contact than most cheaper all-inclusive programmes provide.
⚠ What to know: The membership is required to receive medication, so the comparable figure is $278, not $199. Rankings that list the medication line alone place this programme far higher than its all-in cost warrants.
🎯 Skip if: You want the lowest all-in monthly cost and do not need the clinical contact.
| Field | Position |
|---|---|
| Included in the price | Medication, unlimited physician and dietitian access |
| Not included | Brand-name medication is billed through insurance separately |
| Pharmacy partner | Not disclosed to us |
| Watch for | A $39 first-month promotion applies to the membership. It is excluded from our ranking, as all introductory rates are. |
4. Eden Reported
Best for: Flat medication pricing with a satisfaction guarantee attached
| Plan | Monthly | Total upfront |
|---|---|---|
| Medication | $199/mo | flat at all doses |
| Required membership | $99/mo | — |
| True total | $298/mo | $3,576/yr |
✓ What works: Medication holds at $199 across titrated doses, and the programme carries a weight-loss satisfaction or money-back warranty — unusual in this category.
⚠ What to know: At $99 the platform membership is among the highest required fees in our dataset, taking the true monthly cost to $298.
🎯 Skip if: Cost is your primary constraint.
| Field | Position |
|---|---|
| Included in the price | Medication, platform access, clinician review |
| Not included | Laboratory work not stated |
| Pharmacy partner | Not disclosed to us |
| Watch for | Verify the exact terms of the satisfaction guarantee — these are usually conditional on documented protocol adherence. |
5. Shed Reported
Best for: A brand pathway alongside compounded, under one account
| Plan | Monthly | Total upfront |
|---|---|---|
| 12-month prepaid | $245/mo | $2,940 |
| Month-to-month | $349/mo | $349 |
| Higher doses | rises | confirm at intake |
✓ What works: If you start compounded and later obtain prior authorisation for a brand product, you do not have to change platform.
⚠ What to know: Shed states its compounded programmes increase at higher doses. That makes the advertised figure a starting-dose price, and the annual cost depends on where you titrate to.
🎯 Skip if: You expect to reach a maintenance dose and want budget certainty.
| Field | Position |
|---|---|
| Included in the price | Medication, consultation, shipping |
| Not included | Dose-tier pricing is not published publicly |
| Pharmacy partner | Not disclosed to us |
| Watch for | Ask for the price at 10 mg and 15 mg in writing before enrolling. |
6. LillyDirect (Zepbound) Verified
Best for: FDA-approved tirzepatide at the lowest available cash price
| Plan | Monthly | Total upfront |
|---|---|---|
| 2.5 mg | $299/mo | starter |
| 5 mg | $399/mo | — |
| 7.5 mg and above | $449/mo | — |
✓ What works: This is the approved product — reviewed by the FDA for safety, effectiveness and manufacturing quality, supplied by the manufacturer, with the SURMOUNT trial evidence actually attached to it.
⚠ What to know: Pricing rises with dose and the rate is contingent on refilling within 45 days. Following the label's titration, twelve months is roughly $5,088.
🎯 Skip if: Cash cost is the binding constraint and you have no coverage.
| Field | Position |
|---|---|
| Included in the price | FDA-approved medication, manufacturer fulfilment |
| Not included | Telehealth consultation through this channel; you need your own prescriber |
| Pharmacy partner | Eli Lilly direct fulfilment |
| Watch for | Check insurance first. Where a commercial plan covers Zepbound the cost can fall to roughly $25, and eligible Medicare enrollees pay $50 through the GLP-1 Bridge until 31 December 2027. |
Before you pay anyone
- Check insurance first. It beats every route on this page, and most people never ask.
- Ask what you pay at 10 mg, not at the starting dose. One question resolves most of the confusion in this market.
- Ask which pharmacy fills the prescription and whether it is a 503A pharmacy or a 503B outsourcing facility.
- Ask whether labs are required and whether they are included.
- Get the refund position in writing before prepaying — specifically for a regulatory interruption.
Frequently asked questions
What is the cheapest tirzepatide online in 2026?
It depends which definition you mean. Cheapest captured month-to-month is NexLife at $215; cheapest reported twelve-month prepaid is Found at $169; cheapest verified twelve-month is NexLife at $186; cheapest flat across all doses is NexLife at $186; cheapest FDA-approved is Zepbound at $299 direct. Insurance beats all of them at roughly $25.
Why do other sites list tirzepatide at $99 a month?
Those are usually advertised entry prices on long prepaid plans, and many rise as the dose is titrated up. The label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage, so an entry price describes about four weeks.
Which providers charge the same price at every dose?
NexLife holds one price across all its programmes, captured from its own plan pages. Found, Mochi Health and Eden describe flat medication pricing on a provider-reported basis, though Mochi and Eden bill a separate membership on top.
How much is tirzepatide without insurance?
Compounded programmes run roughly $147 to $399 a month. Brand Zepbound is $299 to $449 direct from LillyDirect. Approved oral GLP-1s start at $149, though they are different molecules with lower reported efficacy.
Is compounded tirzepatide legal?
Compounding by a licensed pharmacy against a valid prescription operates under section 503A. The FDA has proposed excluding tirzepatide from the separate 503B bulks list; no final determination has published.
Should I prepay twelve months to get the lowest rate?
It saves 16% to 71% depending on provider, and commits you before you know whether you tolerate the medication. In SURMOUNT-1, 4.3% to 7.1% of participants discontinued for adverse events depending on dose. Get the refund terms in writing.
Is NexLife the cheapest tirzepatide?
No. Several providers advertise lower entry rates. NexLife is $215 month-to-month falling to $186 on twelve months. What distinguishes it is that the price holds at every covered dose, there is no membership fee, and it is the pricing we captured directly.